Depression
Publication: Annals of Internal Medicine
Volume 152, Number 9
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
Editor's Note: This issue of In the Clinic has been updated.
Depression affects 5% to 10% of primary care patients (1) on average; however, this varies widely among clinical populations (2, 3). Only about half of depressed patients receive treatment (4). Untreated depression may prevent effective treatment of common co-occurring illnesses, such as diabetes (5). Depression causes disability similar to that of other chronic medical conditions (6, 7). Effective treatment reduces symptoms and improves quality of life (8). Asking about depression is sometimes viewed as "opening Pandora's box," but primary care clinicians …
Get full access to this article
View all available purchase options and get full access to this article.
Supplemental Material
References
1.
Pignone MP, Gaynes BN, Rushton JL, et al. Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;136:765-76. [ 12020146]
2.
Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23:934-42. [ 10895843]
3.
Miranda J, Chung JY, Green BL, et al. Treating depression in predominantly low-income young minority women: a randomized controlled trial. JAMA. 2003;290:57-65. [ 12837712]
4.
González HM, Vega WA, Williams DR, et al. Depression care in the United States: too little for too few. Arch Gen Psychiatry. 2010;67:37-46. [ 20048221]
5.
Katon WJ, Schoenbaum M, Fan MY, et al. Cost-effectiveness of improving primary care treatment of late-life depression. Arch Gen Psychiatry. 2005;62:1313-20. [ 16330719]
6.
Hays RD, Wells KB, Sherbourne CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arch Gen Psychiatry. 1995;52:11-9. [ 7811158]
7.
Remick RA. Diagnosis and management of depression in primary care: a clinical update and review. CMAJ. 2002;167:1253-60. [ 12451082]
8.
Heiligenstein JH, Ware JE Jr, Beusterien KM, et al. Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression. Int Psychogeriatr. 1995;7 Suppl:125-37. [ 8580388]
9.
McDonald WM, Richard IH, DeLong MR. Prevalence, etiology, and treatment of depression in Parkinson’s disease. Biol Psychiatry. 2003;54:363-75. [ 12893111]
10.
Kendler KS, Gardner CO, Prescott CA. Clinical characteristics of major depression that predict risk of depression in relatives. Arch Gen Psychiatry. 1999;56:322-7. [ 10197826]
11.
Runeson B, Asberg M. Family history of suicide among suicide victims. Am J Psychiatry. 2003;160:1525-6. [ 12900320]
12.
Beck CT. Predictors of postpartum depression: an update. Nurs Res. 2001;50:275-85. [ 11570712]
13.
Person C, Tracy M, Galea S. Risk factors for depression after a disaster. J Nerv Ment Dis. 2006;194:659-66. [ 16971817]
14.
Risch N, Herrell R, Lehner T, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA. 2009;301:2462-71. [ 19531786]
15.
O’Connor EA, Whitlock EP, Beil TL, et al. Screening for depression in adult patients in primary care settings: a systematic evidence review. Ann Intern Med. 2009;151:793-803. [ 19949145]
16.
Terre L, Poston WS, Foreyt J, et al. Do somatic complaints predict subsequent symptoms of depression? Psychother Psychosom. 2003;72:261-7. [ 12920330]
17.
Whooley MA, Avins AL, Miranda J, et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med. 1997;12: 439-45. [ 9229283]
18.
Mulrow CD, Williams JW Jr, Gerety MB, et al. Case-finding instruments for depression in primary care settings. Ann Intern Med. 1995;122:913-21. [ 7755226]
19.
Diagnosis and Statisitical Manual of Mental Disorders 4th Edition. Washington, DC: American Pyschiatric Association; 1994.
20.
Beck AT, Steer RA, Brown GK. BDI-II, Beck Depression Inventory: Manual. 2nd ed. Boston: Harcourt-Brace; 1996.
21.
Georgiopoulos AM, Bryan TL, Yawn BP, et al. Population-based screening for postpartum depression. Obstet Gynecol. 1999;93:653-7. [ 10912961]
22.
Yesavage JA. Geriatric Depression Scale. Psychopharmacol Bull. 1988;24:709-11. [ 3249773]
23.
Alexopoulos GS, Abrams RC, Young RC, et al. Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988;23:271-84. [ 3337862]
24.
Löwe B, Unützer J, Callahan CM, et al. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42:1194-201. [ 15550799]
25.
Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303:47-53. [ 20051569]
26.
Thase ME, Greenhouse JB, Frank E, et al. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry. 1997;54:1009-15. [ 9366657]
27.
Depression in primary care: detection, diagnosis, and treatment. Agency for Healthcare Policy and Research. Clin Pract Guidel Quick Ref Guide Clin. 1993;5:1-20.
28.
Moscicki EK. Identification of suicide risk factors using epidemiologic studies. Psychiatr Clin North Am. 1997;20:499-517. [ 9323310]
29.
Brody DS, Thompson TL 2nd, Larson DB, et al. Recognizing and managing depression in primary care. Gen Hosp Psychiatry. 1995;17:93-107. [ 7789790]
30.
Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005;294:2064-74. [ 16249421]
31.
Vaiva G, Vaiva G, Ducrocq F, et al. Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ. 2006;332:1241-5. [ 16735333]
32.
Stanford EJ, Goetz RR, Bloom JD. The No Harm Contract in the emergency assessment of suicidal risk. J Clin Psychiatry. 1994;55:344-8. [ 8071303]
33.
Garvey KA, Penn JV, Campbell AL, et al. Contracting for safety with patients: clinical practice and forensic implications. J Am Acad Psychiatry Law. 2009;37:363-70. [ 19767501]
34.
Karch DL, Barker L, Strine TW. Race/ethnicity, substance abuse, and mental illness among suicide victims in 13 US states: 2004 data from the National Violent Death Reporting System. Inj Prev. 2006;12 Suppl 2:ii22-ii27. [ 17170166]
35.
Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003;64:53-9. [ 12590624]
36.
Goldberg JF, Ernst CL. Features associated with the delayed initiation of mood stabilizers at illness onset in bipolar disorder. J Clin Psychiatry. 2002;63:985-91. [ 12444811]
37.
Paykel ES, Scott J, Teasdale JD, et al. Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry. 1999;56:829-35. [ 12884889]
38.
Fava GA, Rafanelli C, Grandi S, et al. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression. Am J Psychiatry. 1998;155:1443-5. [ 9766780]
39.
Kessler D, Lewis G, Kaur S, et al. Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet. 2009;374:628-34. [ 19700005]
40.
Warmerdam L, van Straten A, Twisk J, et al. Internet-based treatment for adults with depressive symptoms: randomized controlled trial. J Med Internet Res. 2008;10:e44. [ 19033149]
41.
Clinical Efficacy Assessment Subcommittee of American College of Physicians. Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;149:725-33. [ 19017591]
42.
Cipriani A, La Ferla T, Furukawa TA, et al. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2010:CD006117. [ 20091586]
43.
Williams JW Jr, Mulrow CD, Chiquette E, et al. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med. 2000;132:743-56. [ 10787370]
44.
STAR*D Study Team. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243-52. [ 16554526]
45.
Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients’ adherence to antidepressant therapy. Med Care. 1995;33:67-74. [ 7823648]
46.
Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA. 2000;283:212-20. [ 10634337]
47.
Dubicka B, Hadley S, Roberts C. Suicidal behaviour in youths with depression treated with new-generation antidepressants: meta-analysis. Br J Psychiatry. 2006;189:393-8. [ 17077427]
48.
Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880. [ 19671933]
49.
Grunebaum MF, Ellis SP, Li S, et al. Antidepressants and suicide risk in the United States, 1985-1999. J Clin Psychiatry. 2004;65:1456-62. [ 15554756]
50.
Reynolds CF 3rd, Dew MA, Pollock BG, et al. Maintenance treatment of major depression in old age. N Engl J Med. 2006;354:1130-8. [ 16540613]
51.
Spier SA. Use of bupropion with SRIs and venlafaxine. Depress Anxiety. 1998;7:73-5. [ 9614595]
52.
Carpenter LL, Jocic Z, Hall JM, et al. Mirtazapine augmentation in the treatment of refractory depression. J Clin Psychiatry. 1999;60:45-9. [ 10074878].
53.
Shelton RC, Papakostas GI. Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder. Acta Psychiatr Scand. 2008;117:253-9. [ 18190674]
54.
Candy M, Jones L, Williams R, et al. Psychostimulants for depression. Cochrane Database Syst Rev. 2008:CD006722. [ 18425966]
55.
Hardy SE. Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. Am J Geriatr Pharmacother. 2009;7:34-59. [ 19281939]
56.
Obrocea G. Thyroid hormone augmentation in treatment resistant depression. Clin Pyschopharmacol Neurosci. 2008;6:3-10
57.
Cooper-Kazaz R, Lerer B. Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors. Int J Neuropsychopharmacol. 2008;11:685-99. [ 18047754]
58.
Carney RM, Freedland KE, Rubin EH, et al. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA. 2009;302:1651-7. [ 19843899]
59.
Golden RN, Gaynes BN, Ekstrom RD, et al. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005;162:656-62. [ 15800134]
60.
Mead GE, Morley W, Campbell P, et al. Exercise for depression. Cochrane Database Syst Rev. 2009:CD004366. [ 19588354]
61.
Morgan AJ, Jorm AF. Self-help interventions for depressive disorders and depressive symptoms: a systematic review. Ann Gen Psychiatry. 2008;7:13. [ 18710579]
62.
Nurnberg HG, Hensley PL. Selective phosphodiesterase type-5 inhibitor treatment of serotonergic reuptake inhibitor antidepressant-associated sexual dysfunction: a review of diagnosis, treatment, and relevance. CNS Spectr. 2003;8:194-202. [ 12595814]
63.
Wright SK, Schroeter S. Hyponatremia as a complication of selective serotonin reuptake inhibitors. J Am Acad Nurse Pract. 2008;20:47-51. [ 18184165]
64.
Osteoporotic Fractures in Men Study Group. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med. 2007;167:1246-51. [ 17592097]
65.
Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Arch Intern Med. 2009;169:2128-39. [ 20008698]
66.
O’Connor CM, Jiang W, Kuchibhatla M, et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med. 2008;168:2232-7. [ 19001200]
67.
Linde K, Berner MM, Kriston L. St John’s wort for major depression. Cochrane Database Syst Rev. 2008:CD000448. [ 18843608]
68.
Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John’s Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther. 2000;294:88-95. [ 10871299]
69.
de Maat MM, Hoetelmans RM, Math RA, et al. Drug interaction between St John’s wort and nevirapine. AIDS. 2001;15:420-1. [ 11273226]
70.
Ondrizek RR, Chan PJ, Patton WC, et al. Inhibition of human sperm motility by specific herbs used in alternative medicine. J Assist Reprod Genet. 1999;16:87-91. [ 10079411]
71.
Pies R. Handbook of Essential Psychopharmacology, second ed. American Psychiatric Publishing; 2005.
72.
Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579-87. [ 16467545]
73.
U.S. Food and Drug Administration. FDA Public Health Advisory: Treatment Challenges of Depression in Pregnancy. 2006. Accessed at www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm124348.htm on 25 March 2010.
74.
Einarson A, Pistelli A, DeSantis M, et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry. 2008;165:749-52. [ 18381907]
75.
Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499-507. [ 16449615]
76.
Miller LJ. Psychiatric medication during pregnancy: understanding and minizing risks. Psychiatr Ann. 1994;24:69-75.
77.
Delgado PL. Approaches to the enhancement of patient adherence to antidepressant medication treatment. J Clin Psychiatry. 2000;61 Suppl 2:6-9. [ 10714617]
78.
Ong MK, Rubenstein LV. Wishing upon a STAR*D: the promise of ideal depression care by primary care providers. Psychiatr Serv. 2009;60:1460-2. [ 19880461]
79.
Gilbody S, Bower P, Fletcher J, et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med. 2006;166:2314-21. [ 17130383]
80.
Weissman MM, Olfson M. Translating intergenerational research on depression into clinical practice. JAMA. 2009;302:2695-6. [ 20040558]
81.
Gilbody S, Sheldon T, House A. Screening and case-finding instruments for depression: a meta-analysis. CMAJ. 2008;178:997-1003. [ 18390942]
82.
Unutzer J, Katon WJ, Fan MY, et al. Long-term cost effects of collaborative care for late-life depression. Am J Manag Care. 2008;14:95-100. [ 18269305]
83.
Bower P, Rowland N. Effectiveness and cost effectiveness of counselling in primary care. Cochrane Database Syst Rev. 2006;3:CD001025. [ 16855955]
84.
Sherbourne CD, Wells KB, Duan N, et al. Long-term effectiveness of disseminating quality improvement for depression in primary care. Arch Gen Psychiatry. 2001;58:696-703. [ 11448378]
Information & Authors
Information
Published In
Annals of Internal Medicine
Volume 152 • Number 9 • 4 May 2010
Pages: ITC5-1
Editors: Barbara Turner, MD, MSED, Sankey Williams, MD, and Darren Taichman, MD, PhD
History
Published online: 4 May 2010
Published in issue: 4 May 2010
Keywords
Copyright
© 2010 American College of Physicians.
Authors
Metrics & Citations
Metrics
Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
Download article citation data for:
Depression. Ann Intern Med.2010;152:ITC5-1. [Epub 4 May 2010]. doi:10.7326/0003-4819-152-9-201005040-01005
Depression. Ann Intern Med.2010;152:ITC5-1. [Epub 4 May 2010]. doi:10.7326/0003-4819-152-9-201005040-01005
View More
Login Options:
Purchase
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.
Create your Free Account
You will be redirected to acponline.org to create an account that will provide access to Annals.
Comments
0 Comments